Invention Grant
- Patent Title: Benzoimidazol-2-yl pyrimidine modulators of the histamine H4 receptor
-
Application No.: US15047359Application Date: 2016-02-18
-
Publication No.: US09434715B2Publication Date: 2016-09-06
- Inventor: Matteo Conza , Magali B. Hickey , Stefan Horns , Susanne Lochner
- Applicant: Janssen Pharmaceutica NV
- Applicant Address: BE Beerse
- Assignee: Janssen Pharmaceutica NV
- Current Assignee: Janssen Pharmaceutica NV
- Current Assignee Address: BE Beerse
- Main IPC: A61K31/506
- IPC: A61K31/506 ; C07D401/14 ; C07C51/43 ; C30B7/08 ; C30B29/54
Abstract:
Benzoimidazol-2-yl pyrimidines, purification methods for the same, and pharmaceutical compositions and methods for the treatment of disease states, disorders, and conditions mediated by H4 receptor activity, including allergy, asthma, autoimmune diseases, and pruritus.
Public/Granted literature
- US20160159775A1 BENZOIMIDAZOL-2-YL PYRIMIDINE MODULATORS OF THE HISTAMINE H4 RECEPTOR Public/Granted day:2016-06-09
Information query
IPC分类:
